A multidisciplinary approach to therapy for unresectable malignant thymoma

Annals of Internal Medicine

Volumn 129, Issue 2, 1998, Pages 100-104

  Shin, Dong M ^a   Walsh, Garrett L ^a   Komaki, Ritsuko ^a   Putnam, Joe B ^a   Nesbitt, Jonathan ^a,b   Ro, Jae Y ^a   Shin, Hyung Ju C ^a   Ki, Keun H ^a   Wimberly, Amanda ^a   Pisters, Katherine M W ^a   Schrump, David ^a,c   Gregurich, Mary Ann ^a,d   Cox, James D ^a   Roth, Jack A ^a   Hong, Waun Ki ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b Cardiovascular Surgery Associates   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d Applied Logic Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SURVIVAL TIME; THYMUS CANCER; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 15644365666     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-129-2-199807150-00006     Document Type: Article

References (20)

1. Thomas CR Jr, Bonomi P. Mediastinal tumors. Curr Opin Oncol. 1990;2: 359-67.
2. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymoma with special reference to their clinical stages. Cancer. 1981;48: 2485-92.
3. Verley JM, Hollmann KH. Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer. 1985;55:1074-86.
4. Maggi G, Giaccone G, Donadio M, Ciuffreda L, Dalesio O, Leria G, et al. Thymomas. A review of 169 cases, with particular reference to results of surgical treatment. Cancer. 1986;58:765-76.
5. Cells JE, Cells A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci U S A. 1985;82:3262-6.
6. Yang WI, Efird JT, Quintanilla-Martinez L, Choi N, Harris NL. Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies. Hum Pathol. 1996;27:70-6.
7. Komaki R, Cox JD. The lung and thymus. In: Cox JD. Moss' Radiation Oncology: Rationale, Technique, Results. 7th ed. St. Louis: Mosby-Year Book; 1994:320-51.
8. Uematsu M, Yoshida H, Kondo M, Itami J, Hatano K, Isobe K, et al. Entire hemithorax irradiation following complete resection in patients with stage II-III invasive thymoma. Int J Radiat Oncol Biol Phys. 1996;35:357-60.
9. Blumberg D, Port JL, Weksler B, Delgado R, Rosai J, Bains MS, et al. Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg. 1995;60:908-13.
10. McCart JA, Gaspar L, Inculet R, Casson AG. Predictors of survival following surgical resection of thymoma. J Surg Oncol. 1993;54:233-8.
11. Loehrer PJ Sr, Perez CA, Roth LM, Greco A, Livingston RB, Einhorn LH. Chemotherapy for advanced thymoma. Preliminary results of an intergroup study. Ann Intern Med. 1990;113:520-4.
12. Loehrer PJ Sr, Kim K, Aisner SC, Livingston R, Einhorn LH, Johnson D, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group. J Clin Oncol. 1994;12:1164-8.
13. Park HS, Shin DM, Lee JS, Komaki R, Pollack A, Putnam JB, et al. Thymoma. A retrospective study of 87 cases. Cancer. 1994;73:2491-8.
14. Giaccone G, Ardizzoni A, Kirkpatrick A, Clerico M, Sahmoud T, van Zandwijk A. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol. 1996;14:814-20.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association. 1958;53:457-81.
16. Cowen D, Richaud P, Mornex F, Bachelot T, Jung GM, Mirabel X, et al. Thymoma: results of a multicentric retrospective series of 149 non-metastatic irradiated patients and review of the literature. FNCLCC trialists. Federation Nationale des Centres de Lutte Contre le Cancer. Radiother Oncol. 1995;34:9-16.
17. Berruti A, Borasio P, Roncari A, Gorzegno G, Mossetti C, Dogliotti L. Neoadjuvant chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide (ADOC) in invasive thymomas: results in six patients. Ann Oncol. 1993;4:429-31.
18. Macchiarini P, Chella A, Ducci F, Rossi B, Testi C, Bevilacqua G, et al. Neoadjuvant chemotherapy, surgery, and postoperative radiation therapy for invasive thymoma. Cancer. 1991;68:706-13.
19. Rea F, Sartori F, Loy M, Calabro F, Fornasiero A, Daniele O, et al. Chemotherapy and operation for invasive thymoma. J Thorac Cardiovasc Surg. 1993;106:543-9.
20. Loehrer PJ Sr, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial. J Clin Oncol. 1997;15:3093-9.